BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 10837064)

  • 21. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1.
    Doody GM; Dempsey PW; Fearon DT
    Curr Opin Immunol; 1996 Jun; 8(3):378-82. PubMed ID: 8793993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement's participation in acquired immunity.
    Nielsen CH; Leslie RG
    J Leukoc Biol; 2002 Aug; 72(2):249-61. PubMed ID: 12149415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The B lymphocyte as an immunotherapeutic target.
    Fearon DT
    QJM; 1995 Mar; 88(3):149-53. PubMed ID: 7539331
    [No Abstract]   [Full Text] [Related]  

  • 25. CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses.
    Tedder TF; Haas KM; Poe JC
    Biochem Soc Trans; 2002 Aug; 30(4):807-11. PubMed ID: 12196203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of complement and complement receptors in induction and regulation of immunity.
    Carroll MC
    Annu Rev Immunol; 1998; 16():545-68. PubMed ID: 9597141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting antigen to CD19 on B cells efficiently activates T cells.
    Yan J; Wolff MJ; Unternaehrer J; Mellman I; Mamula MJ
    Int Immunol; 2005 Jul; 17(7):869-77. PubMed ID: 15967786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
    Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
    Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA; Morris MA; Holers VM; Karp DR
    J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens.
    Cherukuri A; Cheng PC; Pierce SK
    J Immunol; 2001 Jul; 167(1):163-72. PubMed ID: 11418645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of the complement C3 protein in the control of the specific immune response].
    Villiers CL; Villiers MB; Marche PN
    Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification.
    Fujimoto M; Poe JC; Hasegawa M; Tedder TF
    Immunol Res; 2000; 22(2-3):281-98. PubMed ID: 11339363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R; Carroll MC
    Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
    Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A
    Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
    Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
    J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD21 and CD19 deficiency: Two defects in the same complex leading to different disease modalities.
    Wentink MW; Lambeck AJ; van Zelm MC; Simons E; van Dongen JJ; IJspeert H; Schölvinck EH; van der Burg M
    Clin Immunol; 2015 Dec; 161(2):120-7. PubMed ID: 26325596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L; Chen K; Huber BT; Holers VM
    Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis.
    Del Nagro CJ; Kolla RV; Rickert RC
    J Immunol; 2005 Oct; 175(8):5379-89. PubMed ID: 16210644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic CD21 deficiency is associated with hypogammaglobulinemia.
    Thiel J; Kimmig L; Salzer U; Grudzien M; Lebrecht D; Hagena T; Draeger R; Voelxen N; Bergbreiter A; Jennings S; Gutenberger S; Aichem A; Illges H; Hannan JP; Kienzler AK; Rizzi M; Eibel H; Peter HH; Warnatz K; Grimbacher B; Rump JA; Schlesier M
    J Allergy Clin Immunol; 2012 Mar; 129(3):801-810.e6. PubMed ID: 22035880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.